Search

Your search keyword '"Hurle, Rodolfo"' showing total 155 results
Start Over Author "Hurle, Rodolfo" Search Limiters Available in Library Collection
155 results on '"Hurle, Rodolfo"'

1. A Propensity Score–matched Comparison of Micro-ultrasound–guided Transrectal and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion-guided Transperineal Prostate Biopsies for Detection of Clinically Significant Prostate Cancer

Author

Piccolini, Andrea, Avolio, Pier Paolo, Saitta, Cesare, Beatrici, Edoardo, Moretto, Stefano, Aljoulani, Muhannad, Dagnino, Filippo, Maffei, Davide, Frego, Nicola, Fasulo, Vittorio, Paciotti, Marco, Hurle, Rodolfo, Saita, Alberto, Lazzeri, Massimo, Casale, Paolo, Colombo, Piergiuseppe, Cieri, Miriam, Buffi, Nicolò Maria, and Lughezzani, Giovanni

Published
2024
Full Text
View/download PDF

3. Prostate cancer risk stratification via eNose urine odor analysis: a preliminary report

Author

Taverna, Gianluigi, primary, Grizzi, Fabio, additional, Bax, Carmen, additional, Tidu, Lorenzo, additional, Zanoni, Matteo, additional, Vota, Paolo, additional, Mazzieri, Cinzia, additional, Clementi, Maria Chiara, additional, Toia, Giovanni, additional, Hegazi, Mohamed A. A. A., additional, Lotesoriere, Beatrice Julia, additional, Hurle, Rodolfo, additional, and Capelli, Laura, additional

Published
2024
Full Text
View/download PDF

4. A Comparative Evaluation of Multiparametric Magnetic Resonance Imaging and Micro-Ultrasound for the Detection of Clinically Significant Prostate Cancer in Patients with Prior Negative Biopsies

Author

Beatrici, Edoardo, primary, Frego, Nicola, additional, Chiarelli, Giuseppe, additional, Sordelli, Federica, additional, Mancon, Stefano, additional, Saitta, Cesare, additional, De Carne, Fabio, additional, Garofano, Giuseppe, additional, Arena, Paola, additional, Avolio, Pier Paolo, additional, Gobbo, Andrea, additional, Uleri, Alessandro, additional, Contieri, Roberto, additional, Paciotti, Marco, additional, Lazzeri, Massimo, additional, Hurle, Rodolfo, additional, Casale, Paolo, additional, Buffi, Nicolò Maria, additional, and Lughezzani, Giovanni, additional

Published
2024
Full Text
View/download PDF

7. The Prognostic Significance of Histological Subtypes in Patients with Muscle-Invasive Bladder Cancer: An Overview of the Current Literature.

Author

Claps, Francesco, Biasatti, Arianna, Di Gianfrancesco, Luca, Ongaro, Luca, Giannarini, Gianluca, Pavan, Nicola, Amodeo, Antonio, Simonato, Alchiede, Crestani, Alessandro, Cimadamore, Alessia, Hurle, Rodolfo, Mertens, Laura S., van Rhijn, Bas W. G., and Porreca, Angelo

Subjects
CLINICAL trials, CANCER invasiveness, TRANSITIONAL cell carcinoma, SURVIVAL rate, TREATMENT effectiveness
Abstract

Bladder cancer (BC) is the tenth most commonly diagnosed malignancy worldwide. In approximately 25% of cases, it presents as a muscle-invasive disease, requiring a radical treatment. Traditionally, the mainstay of treatment has been radical cystectomy (RC), but in the last decade, bladder-sparing treatments have been gaining growing interest. In particular, trimodal therapy (TMT) seems to yield survival results comparable to RC with less morbidity and better quality of life (QoL) outcomes. In this scenario, we aimed at shedding light on the role of the histological subtypes (HS) of BC and their prognostic significance in muscle-invasive BC (MIBC), treated either surgically or with TMT. We performed a narrative review to provide an overview of the current literature on this topic. When compared with patients diagnosed with conventional urothelial carcinoma (UC) of the same disease stage, survival did not appear to be significantly worse across the reports. But when sub-analyzed for separate subtype, some appeared to be independently associated with adverse survival outcomes such as the micropapillary, plasmacytoid, small-cell, and sarcomatoid subtypes, whereas others did not. Moreover, the optimal management remains to be defined, also depending on the therapeutic susceptibility of each histology. From this perspective, multi-disciplinary assessment alongside the routine inclusion of such entities in randomized clinical trials appears to be essential. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

8. Nutritional Prehabilitation in Patients Undergoing Cystectomy: A Systematic Review.

Author

Dal Bello, Susy, Mancin, Stefano, Morales Palomares, Sara, Lopane, Diego, Di Gianfrancesco, Luca, Soligo, Chiara, Tarantino, Tommaso, Perdonò, Paolo, Hurle, Rodolfo, Bernardini, Bruno, Piccioni, Federico, Pastore, Manuela, Pellegrinelli, Alvarez, Porreca, Angelo, and Mazzoleni, Beatrice

Abstract

Background/Aim: Nutrition is a key element of the prehabilitation process prior to surgery. The aim of this study was to identify the clinical pathways of nutritional prehabilitation before cystectomy. Methods: A systematic literature review was conducted in PubMed, the Cochrane Library, CINAHL, Scopus and the Web of Science databases. Quality and risk of bias assessment was conducted adhering to the JBI framework and evidence was evaluated according to the Oxford Centre for Evidence Based Medicine levels of evidence. Results: Out of 586 records identified, six studies were included. Among them, only two were randomized controlled trials. Immunonutrition has been shown to improve postoperative bowel function (3.12 vs. 3.74 days; RR 0.82; CI, 0.73–0.93; p = 0.0029) and decrease postoperative complications (−36.7%; p = 0.008) and readmission rates (−15.38%; p = 0.03). Furthermore, oral nutritional supplements combined with nutritional counseling demonstrated an accelerated recovery of bowel function (−1 day; p < 0.01), a reduction in the length of hospital stay (−1.75 days; p = 0.01), an improvement in handgrip strength (+6.8%, p < 0.001), an increase in bone mass (+0.3 kg, p = 0.04), and a better BMI value (+2.3%, p = 0.001). Conclusions: Nutritional prehabilitation demonstrates potential in enhancing postoperative outcomes following radical cystectomy. Oral supplements, immunonutrition, and counseling exhibit efficacy in improving postoperative results. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

9. Preoperative Age and Its Impact on Long-Term Renal Functional Decline after Robotic-Assisted Partial Nephrectomy: Insights from a Tertiary Referral Center.

Author

Saitta, Cesare, Garofano, Giuseppe, Lughezzani, Giovanni, Meagher, Margaret F., Yuen, Kit L., Fasulo, Vittorio, Diana, Pietro, Uleri, Alessandro, Piccolini, Andrea, Mancon, Stefano, Arena, Paola, Sordelli, Federica, Mantovani, Matilde, Avolio, Pier Paolo, Beatrici, Edoardo, Hurle, Rodolfo F., Lazzeri, Massimo, Saita, Alberto, Casale, Paolo, and Derweesh, Ithaar H.

Subjects
NEPHRECTOMY, ACUTE kidney failure, GLOMERULAR filtration rate, CHRONIC kidney failure, OLDER patients
Abstract

Background and Objectives: to investigate the impact of age on renal function deterioration after robotic-assisted partial nephrectomy (RAPN) focusing on a decline to moderate and severe forms of chronic kidney disease (CKD). Materials and Methods: This is a single center prospective analysis of patients who underwent RAPN. The outcomes include the development of de novo CKD-S 3a [estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m2)] and de novo CKD-S 3b (eGFR < 45 mL/min/1.73/m2). Multivariable analysis (MVA) via Cox regression identified predictors for CKD-S 3a/b. Kaplan –Meier Analyses (KMA) were fitted for survival assessment. Multivariable linear regression was utilized to identify the predictors of last-eGFR. Results: Overall, 258 patients were analyzed [low age (<50) n = 40 (15.5%); intermediate age (50–70) n = 164 (63.5%); high age (>70) n = 54 (20.9%)] with a median follow-up of 31 (IQR 20–42) months. MVA revealed an increasing RENAL score [Hazard Ratio (HR) 1.32, p = 0.009], age 50–70 (HR 6.21, p = 0.01), age ≥ 70 (HR 10.81, p = 0.001), increasing BMI (HR 1.11, p < 0.001) and preoperative CKD 2 (HR 2.43, p = 0.014) are independent risk factors associated with an increased risk of CKD-S 3a; conversely, post-surgical acute kidney injury was not (p = 0.83). MVA for CKD-S 3b revealed an increasing RENAL score (HR 1.51, p = 0.013) and age ≥ 70 (HR 2.73, p = 0.046) are associated with an increased risk of CKD-S 3b. Linear regression analysis revealed increasing age (Coeff. −0.76, p < 0.001), increasing tumor size (Coeff. −0.31, p = 0.03), and increasing BMI (Coeff. −0.64, p = 0.004) are associated with decreasing eGFR at last follow-up. We compare the survival distribution of our cohort stratified by age elderly patients experienced worsened CKD-S 3a/b disease-free survival (p < 0.001; p < 0.001, respectively). Conclusions: Age is independently associated with a greater risk of significant and ongoing decline in kidney function following RAPN. Recognizing the impact of aging on renal function post-surgery can guide better management practices. Further investigations are required. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

10. Early Detection of Prostate Cancer: The Role of Scent

Author

Grizzi, Fabio, primary, Bax, Carmen, additional, Hegazi, Mohamed A. A. A., additional, Lotesoriere, Beatrice Julia, additional, Zanoni, Matteo, additional, Vota, Paolo, additional, Hurle, Rodolfo Fausto, additional, Buffi, Nicolò Maria, additional, Lazzeri, Massimo, additional, Tidu, Lorenzo, additional, Capelli, Laura, additional, and Taverna, Gianluigi, additional

Published
2023
Full Text
View/download PDF

11. Male awareness of prostate cancer risk remains poor in relatives of women with germline variants in DNA‐repair genes

Author

Fasulo, Vittorio, primary, Buffi, NicolòMaria, additional, Chiarelli, Giuseppe, additional, Lughezzani, Giovanni, additional, Zuradelli, Monica, additional, Ripamonti, Carla Barbara, additional, Barile, Monica, additional, Bianchi, Paolo, additional, Benetti, Alessio, additional, Paciotti, Marco, additional, Uleri, Alessandro, additional, Avolio, Pier Paolo, additional, Saita, Alberto, additional, Hurle, Rodolfo, additional, Maura, Federica, additional, Germagnoli, Luca, additional, Asselta, Rosanna, additional, Soldà, Giulia, additional, Casale, Paolo, additional, and Lazzeri, Massimo, additional

Published
2023
Full Text
View/download PDF

12. Evaluation of Semen Self-Sampling Yield Predictors and CTC Isolation by Multi-Color Flow Cytometry for Liquid Biopsy of Localized Prostate Cancer

Author

Saitta, Cesare, primary, De Simone, Ilaria, additional, Fasulo, Vittorio, additional, Corbetta, Marinella, additional, Duga, Stefano, additional, Chiereghin, Chiara, additional, Colombo, Federico Simone, additional, Benetti, Alessio, additional, Contieri, Roberto, additional, Avolio, Pier Paolo, additional, Uleri, Alessandro, additional, Saita, Alberto, additional, Guazzoni, Giorgio Ferruccio, additional, Hurle, Rodolfo, additional, Colombo, Piergiuseppe, additional, Buffi, Nicolò Maria, additional, Casale, Paolo, additional, Lughezzani, Giovanni, additional, Asselta, Rosanna, additional, Soldà, Giulia, additional, and Lazzeri, Massimo, additional

Published
2023
Full Text
View/download PDF

13. Evaluating the Protective Effect of Intravesical Bacillus Calmette-Guerin against SARS-CoV-2 in Non-Muscle Invasive Bladder Cancer Patients: A Multicenter Observational Trial

Author

Hurle, Rodolfo, primary, Soria, Francesco, additional, Contieri, Roberto, additional, Avolio, Pier Paolo, additional, Mancon, Stefano, additional, Lazzeri, Massimo, additional, Bernasconi, Valentina, additional, Mazzoli, Simone, additional, Pizzuto, Giuseppe, additional, De Bellis, Matteo, additional, Rosazza, Matteo, additional, Livoti, Simone, additional, Lupia, Tommaso, additional, Corcione, Silvia, additional, Lillaz, Beatrice, additional, De Rosa, Francesco Giuseppe, additional, Buffi, Nicolò Maria, additional, Kamat, Ashish M., additional, Gontero, Paolo, additional, and Casale, Paolo, additional

Published
2023
Full Text
View/download PDF

14. Prospective Validation of the ROL System in Substaging pT1 High-Grade Urothelial Carcinoma: Results from a Mono-Institutional Confirmatory Analysis in BCG Treated Patients

Author

Valeri, Marina, primary, Contieri, Roberto, additional, Fasulo, Vittorio, additional, Iuzzolino, Martina, additional, Cieri, Miriam, additional, Elefante, Grazia M., additional, De Carlo, Camilla, additional, Bressan, Alessandra, additional, Saitta, Cesare, additional, Gobbo, Andrea, additional, Avolio, Pier Paolo, additional, Dacrema, Valerio, additional, Lazzeri, Massimo, additional, Taverna, Gianluigi, additional, Terracciano, Luigi M., additional, Hurle, Rodolfo, additional, and Colombo, Piergiuseppe, additional

Published
2023
Full Text
View/download PDF

16. Prospective evaluation of the role of imaging techniques and TMPRSS2:ERG mutation for the diagnosis of clinically significant prostate cancer

Author

Lazzeri, Massimo, primary, Fasulo, Vittorio, additional, Lughezzani, Giovanni, additional, Benetti, Alessio, additional, Soldà, Giulia, additional, Asselta, Rosanna, additional, De Simone, Ilaria, additional, Paciotti, Marco, additional, Avolio, Pier Paolo, additional, Contieri, Roberto, additional, Saitta, Cesare, additional, Saita, Alberto, additional, Hurle, Rodolfo, additional, Guazzoni, Giorgio, additional, Buffi, Nicolò Maria, additional, and Casale, Paolo, additional

Published
2022
Full Text
View/download PDF

18. Intratumoral Switch of Molecular Phenotype and Overall Survival in Muscle Invasive Bladder Cancer

Author

De Carlo, Camilla, primary, Valeri, Marina, additional, Rudini, Noemi, additional, Zucali, Paolo, additional, Cieri, Miriam, additional, Elefante, Grazia, additional, D’antonio, Federica, additional, Hurle, Rodolfo, additional, Giordano, Laura, additional, Bressan, Alessandra, additional, Lazzeri, Massimo, additional, Perrino, Matteo, additional, Guazzoni, Giorgio, additional, Terracciano, Luigi, additional, and Colombo, Piergiuseppe, additional

Published
2022
Full Text
View/download PDF

19. Head-to-Head Comparison between High-Resolution Microultrasound Imaging and Multiparametric MRI in Detecting and Local Staging of Bladder Cancer: The BUS-MISS Protocol

Author

Diana, Pietro, primary, Lughezzani, Giovanni, additional, Saita, Alberto, additional, Uleri, Alessandro, additional, Frego, Nicola, additional, Contieri, Roberto, additional, Buffi, Nicolomaria, additional, Balzarini, Luca, additional, D’Orazio, Federico, additional, Piergiuseppe, Colombo, additional, Elefante, Maria Grazia, additional, Lazzeri, Massimo, additional, Guazzoni, Giorgio, additional, Casale, Paolo, additional, and Hurle, Rodolfo, additional

Published
2022
Full Text
View/download PDF

20. Radical Nephroureterectomy Tetrafecta: A Proposal Reporting Surgical Strategy Quality at Surgery

Author

Soria, Francesco, Pradere, Benjamin, Hurle, Rodolfo, D'Andrea, David, Albisinni, Simone, Diamand, Romain, Laukhtina, Ekaterina, Di Trapani, Ettore, Aziz, Atiqullah, Krajewski, Wojciech, Teoh, Jeremy Yuen Chen J.Y., Mari, Andrea, Moschini, Marco, Chiancone, Francesco, Autorino, Riccardo, Porreca, Angelo, Marchioni, Michele, Liguori, Giovanni, Lucarelli, Giuseppe, Busetto, Gian Maria, Foschi, N., Antonelli, Alessandro, Bove, Pierluigi, Russo, Giorgio Ivan, Crisan, Nicolae, Borghesi, Marco, Boeri, Luca, Veccia, Alessandro, Greco, Franesco, Longo, Nicola, De Cobelli, Ottavio, Shariat, Shahrokh S.F., Gontero, Paolo, Ferro, Matteo, Soria, Francesco, Pradere, Benjamin, Hurle, Rodolfo, D'Andrea, David, Albisinni, Simone, Diamand, Romain, Laukhtina, Ekaterina, Di Trapani, Ettore, Aziz, Atiqullah, Krajewski, Wojciech, Teoh, Jeremy Yuen Chen J.Y., Mari, Andrea, Moschini, Marco, Chiancone, Francesco, Autorino, Riccardo, Porreca, Angelo, Marchioni, Michele, Liguori, Giovanni, Lucarelli, Giuseppe, Busetto, Gian Maria, Foschi, N., Antonelli, Alessandro, Bove, Pierluigi, Russo, Giorgio Ivan, Crisan, Nicolae, Borghesi, Marco, Boeri, Luca, Veccia, Alessandro, Greco, Franesco, Longo, Nicola, De Cobelli, Ottavio, Shariat, Shahrokh S.F., Gontero, Paolo, and Ferro, Matteo

Abstract

Background: Standardized methods for reporting surgical quality have been described for all the major urological procedures apart from radical nephroureterectomy (RNU). Objective: To propose a tetrafecta criterion for assessing the quality of RNU based on a consensus panel within the Young Association of Urology (YAU) Urothelial Group, and to test the impact of this tetrafecta in a multicenter, large contemporary cohort of patients treated with RNU for upper tract urothelial carcinoma (UTUC). Design, setting, and participants: This was a retrospective analysis of 1765 patients with UTUC treated between 2000 and 2021. Outcome measurements and statistical analysis: We interviewed the YAU Urothelial Group to propose and score a list of items to be included in the “RNU-fecta.” A ranking was generated for the criteria with the highest sum score. These criteria were applied to a large multicenter cohort of patients. Kaplan-Meier curves were built to evaluate differences in overall survival (OS) rates between groups, and a multivariable logistic regression model was used to find the predictors of achieving the RNU tetrafecta. Results and limitations: The criteria with the highest score included three surgical items such as negative soft tissue surgical margins, bladder cuff excision, lymph node dissection according to guideline recommendations, and one oncological item defined by the absence of any recurrence in ≤12 mo. These items formed the RNU tetrafecta. Within a median follow-up of 30 mo, 52.6% of patients achieved the RNU tetrafecta. The 5-yr OS rates were significantly higher for patients achieving tetrafecta than for their counterparts (76% vs 51%). Younger age, lower body mass index, and robotic approach were found to be independent predictors of tetrafecta achievement. Conversely, a higher Eastern Cooperative Oncology Group score, higher clinical stage, and bladder cancer history were inversely associated with tetrafecta. Conclusions: Herein, we present a “tetraf, SCOPUS: ar.j, info:eu-repo/semantics/published

Published
2022

21. External Validation and Comparison of Two Nomograms Predicting the Probability of Lymph Node Involvement in Patients subjected to Robot-Assisted Radical Prostatectomy and Concomitant Lymph Node Dissection: A Single Tertiary Center Experience in the MRI-Era

Author

Frego, Nicola, primary, Paciotti, Marco, additional, Buffi, Nicolò Maria, additional, Maffei, Davide, additional, Contieri, Roberto, additional, Avolio, Pier Paolo, additional, Fasulo, Vittorio, additional, Uleri, Alessandro, additional, Lazzeri, Massimo, additional, Hurle, Rodolfo, additional, Saita, Alberto, additional, Guazzoni, Giorgio Ferruccio, additional, Casale, Paolo, additional, and Lughezzani, Giovanni, additional

Published
2022
Full Text
View/download PDF

22. Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette–Guerin Immunotherapy

Author

Ferro, Matteo, primary, Tătaru, Octavian Sabin, additional, Musi, Gennaro, additional, Lucarelli, Giuseppe, additional, Abu Farhan, Abdal Rahman, additional, Cantiello, Francesco, additional, Damiano, Rocco, additional, Hurle, Rodolfo, additional, Contieri, Roberto, additional, Busetto, Gian Maria, additional, Carrieri, Giuseppe, additional, Cormio, Luigi, additional, Del Giudice, Francesco, additional, Sciarra, Alessandro, additional, Perdonà, Sisto, additional, Borghesi, Marco, additional, Terrone, Carlo, additional, La Civita, Evelina, additional, Bove, Pierluigi, additional, Autorino, Riccardo, additional, Muto, Matteo, additional, Crisan, Nicolae, additional, Marchioni, Michele, additional, Schips, Luigi, additional, Soria, Francesco, additional, Terracciano, Daniela, additional, Papalia, Rocco, additional, Crocetto, Felice, additional, Barone, Biagio, additional, Russo, Giorgio Ivan, additional, Luzzago, Stefano, additional, Ludovico, Giuseppe Mario, additional, Vartolomei, Mihai Dorin, additional, Mistretta, Francesco Alessandro, additional, Mirone, Vincenzo, additional, and de Cobelli, Ottavio, additional

Published
2022
Full Text
View/download PDF

23. Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under “Active Surveillance” for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study

Author

Fasulo, Vittorio, primary, Paciotti, Marco, additional, Lazzeri, Massimo, additional, Contieri, Roberto, additional, Casale, Paolo, additional, Saita, Alberto, additional, Lughezzani, Giovanni, additional, Diana, Pietro, additional, Frego, Nicola, additional, Avolio, Pier Paolo, additional, Colombo, Piergiuseppe, additional, Elefante, Grazia Maria, additional, Guazzoni, Giorgio, additional, Buffi, Nicolò Maria, additional, Bates, Michael, additional, and Hurle, Rodolfo, additional

Published
2022
Full Text
View/download PDF

24. Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer

Author

Masetti, Michela, primary, Carriero, Roberta, additional, Portale, Federica, additional, Marelli, Giulia, additional, Morina, Nicolò, additional, Pandini, Marta, additional, Iovino, Marta, additional, Partini, Bianca, additional, Erreni, Marco, additional, Ponzetta, Andrea, additional, Magrini, Elena, additional, Colombo, Piergiuseppe, additional, Elefante, Grazia, additional, Colombo, Federico Simone, additional, den Haan, Joke M.M., additional, Peano, Clelia, additional, Cibella, Javier, additional, Termanini, Alberto, additional, Kunderfranco, Paolo, additional, Brummelman, Jolanda, additional, Chung, Matthew Wai Heng, additional, Lazzeri, Massimo, additional, Hurle, Rodolfo, additional, Casale, Paolo, additional, Lugli, Enrico, additional, DePinho, Ronald A., additional, Mukhopadhyay, Subhankar, additional, Gordon, Siamon, additional, and Di Mitri, Diletta, additional

Published
2021
Full Text
View/download PDF

25. The Impact of SARS-CoV-2 Pandemic on Time to Primary, Secondary Resection and Adjuvant Intravesical Therapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer: A Retrospective Multi-Institutional Cohort Analysis

Author

Ferro, Matteo, primary, Del Giudice, Francesco, additional, Carrieri, Giuseppe, additional, Busetto, Gian Maria, additional, Cormio, Luigi, additional, Hurle, Rodolfo, additional, Contieri, Roberto, additional, Arcaniolo, Davide, additional, Sciarra, Alessandro, additional, Maggi, Martina, additional, Porpiglia, Francesco, additional, Manfredi, Matteo, additional, Fiori, Cristian, additional, Antonelli, Alessandro, additional, Tafuri, Alessandro, additional, Bove, Pierluigi, additional, Terrone, Carlo, additional, Borghesi, Marco, additional, Costantini, Elisabetta, additional, Iliano, Ester, additional, Montanari, Emanuele, additional, Boeri, Luca, additional, Russo, Giorgio Ivan, additional, Madonia, Massimo, additional, Tedde, Alessandro, additional, Veccia, Alessandro, additional, Simeone, Claudio, additional, Liguori, Giovanni, additional, Trombetta, Carlo, additional, Brunocilla, Eugenio, additional, Schiavina, Riccardo, additional, Dal Moro, Fabrizio, additional, Racioppi, Marco, additional, Vartolomei, Mihai Dorin, additional, Longo, Nicola, additional, Spirito, Lorenzo, additional, Crocetto, Felice, additional, Cantiello, Francesco, additional, Damiano, Rocco, additional, Di Stasi, Savino M., additional, Marchioni, Michele, additional, Schips, Luigi, additional, Parma, Paolo, additional, Carmignani, Luca, additional, Conti, Andrea, additional, Soria, Francesco, additional, Gontero, Paolo, additional, Barone, Biagio, additional, Deho, Federico, additional, Zaffuto, Emanuele, additional, Papalia, Rocco, additional, Scarpa, Roberto M., additional, Pagliarulo, Vincenzo, additional, Lucarelli, Giuseppe, additional, Ditonno, Pasquale, additional, Botticelli, Francesco Maria Gerardo, additional, Musi, Gennaro, additional, Catellani, Michele, additional, and de Cobelli, Ottavio, additional

Published
2021
Full Text
View/download PDF

26. Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy

Author

Ferro, Matteo, primary, Babă, Dragoş-Florin, additional, Cobelli, Ottavio de, additional, Musi, Gennaro, additional, Lucarelli, Giuseppe, additional, Terracciano, Daniela, additional, Porreca, Angelo, additional, Busetto, Gian Maria, additional, Giudice, Francesco Del, additional, Soria, Francesco, additional, Gontero, Paolo, additional, Cantiello, Francesco, additional, Damiano, Rocco, additional, Rocco, Papalia, additional, Scarpa, Roberto Mario, additional, Abu Farhan, Abdal Rahman, additional, Autorino, Riccardo, additional, Brescia, Antonio, additional, Marchioni, Michele, additional, Mari, Andrea, additional, Minervini, Andrea, additional, Longo, Nicola, additional, Chiancone, Francesco, additional, Perdona’, Sisto, additional, Barone, Biagio, additional, Placido, Pietro De, additional, Catellani, Michele, additional, Bottero, Danilo, additional, Ditonno, Pasquale, additional, Battaglia, Michele, additional, Zamboni, Stefania, additional, Antonelli, Alessandro, additional, Greco, Francesco, additional, Russo, Giorgio Ivan, additional, Smelzo, Salvatore, additional, Hurle, Rodolfo, additional, Crisan, Nicolae, additional, Manfredi, Matteo, additional, Porpiglia, Francesco, additional, Crocetto, Felice, additional, Buonerba, Carlo, additional, Danilesco, Alina, additional, and Vartolomei, Mihai Dorin, additional

Published
2021
Full Text
View/download PDF

27. A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy

Author

Ferro, Matteo, primary, Lucarelli, Giuseppe, additional, de Cobelli, Ottavio, additional, Dolce, Pasquale, additional, Terracciano, Daniela, additional, Musi, Gennaro, additional, Porreca, Angelo, additional, Busetto, Gian Maria, additional, Del Giudice, Francesco, additional, Soria, Francesco, additional, Gontero, Paolo, additional, Cantiello, Francesco, additional, Damiano, Rocco, additional, Crocerossa, Fabio, additional, Abu Farhan, Abdal Rahman, additional, Autorino, Riccardo, additional, Vartolomei, Mihai Dorin, additional, Marchioni, Michele, additional, Mari, Andrea, additional, Minervini, Andrea, additional, Longo, Nicola, additional, Celentano, Giuseppe, additional, Chiancone, Francesco, additional, Perdonà, Sisto, additional, Del Prete, Paola, additional, Ditonno, Pasquale, additional, Battaglia, Michele, additional, Zamboni, Stefania, additional, Antonelli, Alessandro, additional, Greco, Francesco, additional, Russo, Giorgio Ivan, additional, Hurle, Rodolfo, additional, Crisan, Nicolae, additional, Manfredi, Matteo, additional, Porpiglia, Francesco, additional, Ribera, Dario, additional, De Placido, Pietro, additional, Facchini, Sergio, additional, Scafuri, Luca, additional, Verde, Antonio, additional, Di Lorenzo, Giuseppe, additional, Cosimato, Vincenzo, additional, Luciano, Angelo, additional, Caputo, Vincenzo Francesco, additional, Crocetto, Felice, additional, and Buonerba, Carlo, additional

Published
2021
Full Text
View/download PDF

28. Post-Biopsy Cell-Free DNA From Blood: An Open Window on Primary Prostate Cancer Genetics and Biology

Author

Corbetta, Marinella, primary, Chiereghin, Chiara, additional, De Simone, Ilaria, additional, Soldà, Giulia, additional, Zuradelli, Monica, additional, Giunta, Michele, additional, Lughezzani, Giovanni, additional, Buffi, Nicolò Maria, additional, Hurle, Rodolfo, additional, Saita, Alberto, additional, Casale, Paolo, additional, Asselta, Rosanna, additional, Lazzeri, Massimo, additional, Guazzoni, Giorgio, additional, and Duga, Stefano, additional

Published
2021
Full Text
View/download PDF

29. Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis

Author

Ferro, Matteo, primary, de Cobelli, Ottavio, additional, Musi, Gennaro, additional, Lucarelli, Giuseppe, additional, Terracciano, Daniela, additional, Pacella, Daniela, additional, Muto, Tommaso, additional, Porreca, Angelo, additional, Busetto, Gian Maria, additional, Del Giudice, Francesco, additional, Soria, Francesco, additional, Gontero, Paolo, additional, Cantiello, Francesco, additional, Damiano, Rocco, additional, Crocerossa, Fabio, additional, Farhan, Abdal Rahman Abu, additional, Autorino, Riccardo, additional, Vartolomei, Mihai Dorin, additional, Muto, Matteo, additional, Marchioni, Michele, additional, Mari, Andrea, additional, Scafuri, Luca, additional, Minervini, Andrea, additional, Longo, Nicola, additional, Chiancone, Francesco, additional, Perdona, Sisto, additional, De Placido, Pietro, additional, Verde, Antonio, additional, Catellani, Michele, additional, Luzzago, Stefano, additional, Mistretta, Francesco Alessandro, additional, Ditonno, Pasquale, additional, Caputo, Vincenzo Francesco, additional, Battaglia, Michele, additional, Zamboni, Stefania, additional, Antonelli, Alessandro, additional, Greco, Francesco, additional, Russo, Giorgio Ivan, additional, Hurle, Rodolfo, additional, Crisan, Nicolae, additional, Manfredi, Matteo, additional, Porpiglia, Francesco, additional, Di Lorenzo, Giuseppe, additional, Crocetto, Felice, additional, and Buonerba, Carlo, additional

Published
2021
Full Text
View/download PDF

30. Oncology and complications

Author

Giordano, Giuseppe, primary, Kyriazi, Evangelia, additional, Mavridis, Charalampos, additional, Persico, Francesco, additional, Fragkoulis, Charalampos, additional, Gatto, Piergiorgio, additional, Georgiadis, George, additional, Giagourta, Irene, additional, Glykas, Ioannis, additional, Hurle, Rodolfo, additional, Lazzeri, Massimo, additional, Lughezzani, Giovanni, additional, Magnano San Lio, Vincenzo, additional, Mamoulakis, Charalampos, additional, Meo, Diego, additional, Papadaki, Helen A., additional, Piaditis, George, additional, Pontikoglou, Charalampos, additional, and Stathouros, Georgios, additional

Published
2021
Full Text
View/download PDF

31. Impact of anti-androgenic therapies on COVID-19: an observational study in male population from a COVID-19 regional centre of Lombardy (Italy)

Author

Duga, Stefano, Asselta, Rosanna, Lazzeri, Massimo, Guazzoni, Giorgio, Azzolini, Elena, Buffi, Nicolo, Fasulo, Vittorio, Persico, Francesco, Saita, Alberto, Hurle, Rodolfo, Lughezzani, Giovanni, and Casale, Paolo

Abstract

There are gender differences in susceptibility and vulnerability to the Coronavirus disease 2019 (COVID-19). The S protein of coronaviruses facilitates viral entry into target cells and employs the host cellular serine protease TMPRSS2 for S protein priming. The TMPRSS2 gene expression is responsive to androgen stimulation and it could partially explain gender differences. We tested the hypothesis that men who received 5-Alpha reductase inhibitors (5ARIs) or androgen deprivation therapy (ADT) for prostate cancer could have a different susceptibility to COVID-19. We carried out an observational study on patients who were referred to our COVID-19 regional centre in Lombardy from 1st to 31st March 2020. Data from 421 patients, 137 women (32.54%) and 284 men (67.44%) with laboratory-confirmed COVID-19, were included in this report. Overall 84 patients died: 28 women (33.33%) and 56 men (66.67%). Among men, 12 patients (4.22%) reported assuming 5ARI treatment, and 6 were under ADT. Over 12 patients under 5ARIs, 3 (25%) died; 2 deaths (33%) were reported in patients under ADT. Our findings showed that only 4.22% of the overall population received 5ARI anti-androgen therapy, a percentage, which revealed to be significantly lower (P

Published
2020
Full Text
View/download PDF

32. Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer

Author

Ferro, Matteo, primary, Di Mauro, Marina, additional, Cimino, Sebastiano, additional, Morgia, Giuseppe, additional, Lucarelli, Giuseppe, additional, Abu Farhan, Abdal Rahman, additional, Vartolomei, Mihai Dorin, additional, Porreca, Angelo, additional, Cantiello, Francesco, additional, Damiano, Rocco, additional, Busetto, Gian Maria, additional, Del Giudice, Francesco, additional, Hurle, Rodolfo, additional, Perdonà, Sisto, additional, Borghesi, Marco, additional, Bove, Pierluigi, additional, Autorino, Riccardo, additional, Crisan, Nicolae, additional, Marchioni, Michele, additional, Schips, Luigi, additional, Soria, Francesco, additional, Mari, Andrea, additional, Minervini, Andrea, additional, Veccia, Alessandro, additional, Battaglia, Michele, additional, Terracciano, Daniela, additional, Musi, Gennaro, additional, Cordima, Giovanni, additional, Muto, Matteo, additional, Mirone, Vincenzo, additional, de Cobelli, Ottavio, additional, and Russo, Giorgio Ivan, additional

Published
2021
Full Text
View/download PDF

34. Could We Safely Avoid a Second Resection in Selected Patients With T1 Non-Muscle-Invasive Bladder Cancer? Preliminary Results of Cost-Effectiveness Study From HUmanitas New Indications for ReTUR (HuNIRe) Multicenter Prospective Trial.

Author

Contieri, Roberto, Lughezzani, Giovanni, Buffi, Nicolò Maria, Taverna, Gianluigi, Giacobbe, Alessandro, Micheli, Emanuele, Barra, Sabato, Colombo, Piergiuseppe, Vanni, Elena, Guazzoni, Giorgio, Lazzeri, Massimo, Hurle, Rodolfo, Casale, Paolo, Saita, Alberto, Gobbo, Andrea, Beatrici, Edoardo, Avolio, Pier Paolo, Uleri, Alessandro, Paciotti, Marco, and Fasulo, Vittorio

Subjects
BLADDER cancer, CANCER invasiveness, COST effectiveness, TUMOR surgery, DISEASE relapse, BACILLUS (Bacteria)
Abstract

Objectives: The aim of this study is to assess whether restaging transurethral resection (ReTUR) could be safely replaced with urine cytology (UC) and in-office fiexible cystoscopy in selected T1 non-muscle-invasive bladder cancer (NMIBC). Materials and Methods: This is an ongoing prospective multicenter trial enrolling patients diagnosed with T1 BC from 5 Italian centers. Patients with a macroscopically incomplete initial resection or absence of detrusor muscle were subjected to ReTUR according to European Association of Urology (EAU) guidelines. Conversely, those with a complete tumor resection at initial TUR underwent UC at 3–4 weeks and in-office fiexible white-light and narrow-band cystoscopy at 4–6 weeks. In case of positive UC, or evidence of recurrence at cystoscopy, ReTUR was performed within 2 weeks. Otherwise, patients started Bacillus Calmette–Guérin (BCG) induction course without ReTUR. The primary endpoint was to determine the feasibility and the clinical utility of not performing ReTUR in selected T1 NMIBC patients. The secondary endpoint was to perform a cost–benefit analysis of this alternative approach. Results: Since May 2020, among 87 patients presenting with T1, 76 patients were enrolled. Nineteen (25%) patients underwent standard ReTUR after initial resection, 10 (13.2%) due to the absence of the detrusor muscle and 9 (11.8%) due to a macroscopically incomplete initial TUR. Overall, 57 (75%) patients initially avoided immediate ReTUR and underwent UC plus in-office flexible cystoscopy. Among them, 38 (66.7%) had no evidence of residual disease and immediately started the BCG induction course. Nineteen patients (33.3%) underwent "salvage" ReTUR due to either positive UC (7; 12.3%) or suspicious cystoscopy (12; 21%). Considering only the patients who initially avoided the ReTUR, disease recurrence was observed in 10/57. The saving of resource for each safely avoided ReTUR was estimated to be 1,759 €. Considering the entire sample, we estimated a saving of 855 € per patient if compared with the EAU guideline approach. Conclusion: The preliminary results of our trial suggested that ReTUR might be safely avoided in highly selected T1 BC patients with a complete resection at first TUR. Longer follow-up and larger sample size are needed to investigate the long-term oncological outcomes of this alternative approach. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

35. Intravesical gemcitabine as bladder‐preserving treatment for BCG unresponsive non‐muscle‐invasive bladder cancer. Results from a single‐arm, open‐label study

Author

Hurle, Rodolfo, primary, Casale, Paolo, additional, Morenghi, Emanuela, additional, Saita, Alberto, additional, Buffi, Nicolòmaria, additional, Lughezzani, Giovanni, additional, Colombo, Piergiuseppe, additional, Contieri, Roberto, additional, Frego, Nicola, additional, Guazzoni, Giorgio, additional, and Lazzeri, Massimo, additional

Published
2020
Full Text
View/download PDF

37. Predictors of Residual T1 High Grade on Re-Transurethral Resection in a Large Multi-Institutional Cohort of Patients with Primary T1 High-Grade/Grade 3 Bladder Cancer

Author

Ferro, Matteo, primary, Di Lorenzo, Giuseppe, additional, Buonerba, Carlo, additional, Lucarelli, Giuseppe, additional, Russo, Giorgio Ivan, additional, Cantiello, Francesco, additional, Farhan, Abdal Rahman Abu, additional, Di Stasi, Savino, additional, Musi, Gennaro, additional, Hurle, Rodolfo, additional, Vincenzo, Serretta, additional, Busetto, Gian Maria, additional, De Berardinis, Ettore, additional, Perdonà, Sisto, additional, Borghesi, Marco, additional, Schiavina, Riccardo, additional, Almeida, Gilberto L., additional, Bove, Pierluigi, additional, Lima, Estevao, additional, Grimaldi, Giovanni, additional, Matei, Deliu Victor, additional, Mistretta, Francesco Alessandro, additional, Crisan, Nicolae, additional, Terracciano, Daniela, additional, Paolo, Verze, additional, Battaglia, Michele, additional, Guazzoni, Giorgio, additional, Autorino, Riccardo, additional, Morgia, Giuseppe, additional, Damiano, Rocco, additional, Muto, Matteo, additional, Rocca, Roberto La, additional, Mirone, Vincenzo, additional, de Cobelli, Ottavio, additional, and Vartolomei, Mihai Dorin, additional

Published
2018
Full Text
View/download PDF

38. Targeted 11C–choline PET-CT/TRUS software fusion-guided prostate biopsy in men with persistently elevated PSA and negative mpMRI after previous negative biopsy

Author

Lazzeri, Massimo, primary, Lopci, Egesta, additional, Lughezzani, Giovanni, additional, Colombo, Piergiuseppe, additional, Casale, Paolo, additional, Hurle, Rodolfo, additional, Saita, Alberto, additional, Leonardi, Lorenzo, additional, Lista, Giuliana, additional, Peschechera, Roberto, additional, Pasini, Luisa, additional, Rodari, Marcello, additional, Zandegiacomo, Silvia, additional, Benetti, Alessio, additional, Cardone, Pasquale, additional, Mrakic, Federica, additional, Balzarini, Luca, additional, Chiti, Arturo, additional, Guazzoni, Giorgio, additional, and Buffi, Nicolò Maria, additional

Published
2017
Full Text
View/download PDF

39. Modified Glasgow Prognostic Score is Associated With Risk of Recurrence in Bladder Cancer Patients After Radical Cystectomy

Author

Ferro, Matteo, De Cobelli, Ottavio, Buonerba, Carlo, Di Lorenzo, Giuseppe, Capece, Marco, Bruzzese, Dario, Autorino, Riccardo, Bottero, Danilo, Cioffi, Antonio, Matei, Deliu Victor, Caraglia, Michele, Borghesi, Marco, De Berardinis, Ettore, Busetto, Gian Maria, Giovannone, Riccardo, Lucarelli, Giuseppe, Ditonno, Pasquale, Perdonà, Sisto, Bove, Pierluigi, Castaldo, Luigi, Hurle, Rodolfo, Musi, Gennaro, Brescia, Antonio, Olivieri, Michele, Cimmino, Amelia, Altieri, Vincenzo, Damiano, Rocco, Cantiello, Francesco, Serretta, Vincenzo, De Placido, Sabino, Mirone, Vincenzo, Sonpavde, Guru, and Terracciano, Daniela

Subjects
Adult, Aged, 80 and over, Male, Risk, Observational Study, Middle Aged, Cystectomy, Prognosis, Urinary Bladder Neoplasms, Humans, Female, Neoplasm Recurrence, Local, Research Article, Aged, Retrospective Studies
Abstract

Recently, many studies explored the role of inflammation parameters in the prognosis of urinary cancers, but the results were not consistent. The modified Glasgow Prognostic Score (mGPS), a systemic inflammation marker, is a prognostic marker in various types of cancers. The aim of the present study was to investigate the usefulness of the preoperative mGPS as predictor of recurrence-free (RFS), overall (OS), and cancer-specific (CSS) survivals in a large cohort of urothelial bladder cancer (UBC) patients. A total of 1037 patients with UBC were included in this study with a median follow-up of 22 months (range 3–60 months). An mGPS = 0 was observed in 646 patients (62.3%), mGPS = 1 in 297 patients (28.6 %), and mGPS = 2 in 94 patients (9.1%). In our study cohort, subjects with an mGPS equal to 2 had a significantly shorter median RFS compared with subjects with mGPS equal to 1 (16 vs 19 months, hazard ratio [HR] 1.54, 95% CI 1.31–1.81, P

Published
2015

41. Senescent Remodeling of the Innate and Adaptive Immune System in the Elderly Men with Prostate Cancer

Author

Taverna, Gianluigi, Seveso, Mauro, Giusti, Guido, Hurle, Rodolfo, Graziotti, Pierpaolo, Štifter, Sanja, Chiriva-Internati, Maurizio, and Grizzi, Fabio

Subjects
Article Subject
Abstract

Despite years of intensive investigation that has been made in understanding prostate cancer, it remains a major cause of death in men worldwide. Prostate cancer emerges from multiple alterations that induce changes in expression patterns of genes and proteins that function in networks controlling critical cellular events. Based on the exponential aging of the population and the increasing life expectancy in industrialized Western countries, prostate cancer in the elderly men is becoming a disease of increasing significance. Aging is a progressive degenerative process strictly integrated with inflammation. Several theories have been proposed that attempt to define the role of chronic inflammation in aging including redox stress, mitochondrial damage, immunosenescence, and epigenetic modifications. Here, we review the innate and adaptive immune systems and their senescent remodeling in elderly men with prostate cancer.

Published
2014
Full Text
View/download PDF

42. Application and Uses of Electronic Noses for Clinical Diagnosis on Urine Samples: A Review

Author

Capelli, Laura, primary, Taverna, Gianluigi, additional, Bellini, Alessia, additional, Eusebio, Lidia, additional, Buffi, Niccolò, additional, Lazzeri, Massimo, additional, Guazzoni, Giorgio, additional, Bozzini, Giorgio, additional, Seveso, Mauro, additional, Mandressi, Alberto, additional, Tidu, Lorenzo, additional, Grizzi, Fabio, additional, Sardella, Paolo, additional, Latorre, Giuseppe, additional, Hurle, Rodolfo, additional, Lughezzani, Giovanni, additional, Casale, Paolo, additional, Meregali, Sara, additional, and Sironi, Selena, additional

Published
2016
Full Text
View/download PDF

43. Usefulness of pT1 substaging in papillary urothelial bladder carcinoma

Author

Patriarca, Carlo, primary, Hurle, Rodolfo, additional, Moschini, Marco, additional, Freschi, Massimo, additional, Colombo, Piergiuseppe, additional, Colecchia, Maurizio, additional, Ferrari, Lucia, additional, Guazzoni, Giorgio, additional, Conti, Andrea, additional, Conti, Giario, additional, Lucianò, Roberta, additional, Magnani, Tiziana, additional, and Colombo, Renzo, additional

Published
2016
Full Text
View/download PDF

44. Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: an update on the evidence

Author

Lazzeri, Massimo, primary, Hurle, Rodolfo, additional, Casale, Paolo, additional, Buffi, NicolòMaria, additional, Lughezzani, Giovanni, additional, Fiorini, Girolamo, additional, Peschechera, Roberto, additional, Pasini, Luisa, additional, Zandegiacomo, Silvia, additional, Benetti, Alessio, additional, Taverna, Gianluigi, additional, Guazzoni, Giorgio, additional, and Barbagli, Guido, additional

Published
2015
Full Text
View/download PDF

45. Impact of Real-Time Elastography versus Systematic Prostate Biopsy Method on Cancer Detection Rate in Men with a Serum Prostate-Specific Antigen between 2.5 and 10 ng/mL

Author

Taverna, Gianluigi, primary, Magnoni, Paola, additional, Giusti, Guido, additional, Seveso, Mauro, additional, Benetti, Alessio, additional, Hurle, Rodolfo, additional, Colombo, Piergiuseppe, additional, Minuti, Francesco, additional, Grizzi, Fabio, additional, and Graziotti, Pierpaolo, additional

Published
2013
Full Text
View/download PDF

47. Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: an update on the evidence.

Author

Lazzeri, Massimo, Hurle, Rodolfo, Casale, Paolo, Buffi, NicolòMaria, Lughezzani, Giovanni, Fiorini, Girolamo, Peschechera, Roberto, Pasini, Luisa, Zandegiacomo, Silvia, Benetti, Alessio, Taverna, Gianluigi, Guazzoni, Giorgio, and Barbagli, Guido

Abstract

Although the pathophysiology of acute chronic cystitis and other ‘sensory’ disorders, i.e. painful bladder syndrome (PBS) or interstitial cystitis (IC), often remains multifactorial, there is a wide consensus that such clinical conditions may arise from a primary defective urothelium lining or from damaged glycosaminoglycans (GAGs). A ‘cascade’ of events starting from GAG injury, which fails to heal, may lead to chronic bladder epithelial damage and neurogenic inflammation. To restore the GAG layer is becoming the main aim of new therapies for the treatment of chronic cystitis and PBS/IC. Preliminary experiences with GAG replenishment for different pathological conditions involving the lower urinary tract have been reported. There is a range of commercially available intravesical formulations of these components, alone or in combination. Literature evidence shows that exogenous intravesical hyaluronic acid markedly reduces recurrences of urinary tract infections (UTIs). Patients treated with exogenous GAGs have fewer UTI recurrences, a longer time to recurrence and a greater improvement in quality of life. Exogenous intravesical GAGs have been used for the treatment of PBS/IC. Despite the limitations of most of the studies, findings confirmed the role of combination therapy with hyaluronic acid and chondroitin sulfate as a safe and effective option for the treatment of PBS/IC. To prevent and/or treat radiotherapy and chemotherapy induced cystitis, GAG replenishment therapy has been used showing preliminary encouraging results. The safety profile of exogenous GAGs has been reported to be very favourable, without adverse events of particular significance. [ABSTRACT FROM AUTHOR]

Published
2016
Full Text
View/download PDF

48. Abstract PR-03: Randomized presurgical trial of finasteride vs. flutamide vs. placebo in prostate cancer

Author

Zanardi, Silvia, primary, Maffezzini, Massimo, additional, Puntoni, Matteo, additional, Montironi, Rodolfo, additional, Johansson, Harriet, additional, Campora, Sara, additional, Vagge, Alessandra, additional, Rondanina, Gabriella, additional, Bandelloni, Roberto, additional, Turbino, Laura, additional, Mori, Marco, additional, Hurle, Rodolfo, additional, Decobelli, Ottavio, additional, Carmignani, Giorgio, additional, Santinelli, Alfredo, additional, Mazzucchelli, Roberta, additional, Bartels, Peter H., additional, and DeCensi, Andrea, additional

Published
2010
Full Text
View/download PDF

49. Abstract A68: Randomized presurgical trial of finasteride vs. flutamide vs. placebo in prostate cancer

Author

Zanardi, Silvia, primary, Maffezzini, Massimo, additional, Puntoni, Matteo, additional, Montironi, Rodolfo, additional, Johansson, Harriet, additional, Campora, Sara, additional, Vagge, Alessandra, additional, Rondanina, Gabriella, additional, Bandelloni, Roberto, additional, Turbino, Laura, additional, Mori, Marco, additional, Hurle, Rodolfo, additional, Decobelli, Ottavio, additional, Carmignani, Giorgio, additional, Santinelli, Alfredo, additional, Mazzucchelli, Roberta, additional, Bartels, Peter H., additional, and DeCensi, Andrea, additional

Published
2010
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results